The secretome of bone marrow and wharton jelly derived mesenchymal stem cells induces differentiation and neurite outgrowth in SH-SY5Y cells

Stem Cells International

Volumn 2014, Issue , 2014, Pages

  Pires, Ana O ^a,b   Neves Carvalho, Andreia ^a,b   Sousa, Nuno ^a,b   Salgado, António J ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 20; GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DENSITY; CELL DIFFERENTIATION; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STROMA CELL; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEUROBLASTOMA; NEUROPROTECTION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WHARTON JELLY; WHARTON JELLY DERIVED MESENCHYMAL STEM CELL;

EID: 84935029798     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2014/438352     Document Type: Article

References (53)

1. J. G. Emsley, B. D. Mitchell, G. Kempermann, and J. D. Macklis, "Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells," Progress in Neurobiology, vol. 75, no. 5, pp. 321-341, 2005.
2. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for CellularTherapy position statement," Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
3. F. G. Teixeira, M. M. Carvalho, N. Sousa, and A. J. Salgado, "Mesenchymal stem cells secretome: a newparadigmfor central nervous system regeneration?" Cellular and Molecular Life Sciences, vol. 70, pp. 3871-3882, 2013.
4. M. M. Carvalho, F. G. Teixeira, R. L. Reis, N. Sousa, and A. J. Salgado, "Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine," Current Stem Cell Research andTherapy, vol. 6, no. 3, pp. 221-228, 2011.
5. H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., "Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638-14643, 2008.
6. A. C. Hirko, R. Dallasen, S. Jomura, and Y. Xu, "Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells," Stem Cells, vol. 26, no. 11, pp. 2893-2901, 2008.
7. D. Cizkova, J. Rosocha, I. Vanicky, S. Jergova, and M. Cizek, "Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat," Cellular and Molecular Neurobiology, vol. 26, pp. 1167-1180, 2006.
8. H. L. Kyung, H. Suh-Kim, S. C. Ji et al., "Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats," Acta Neurobiologiae Experimentalis, vol. 67, no. 1, pp. 13-22, 2007.
9. G. Bouchez, L. Sensebé, P. Vourc'h et al., "Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease," Neurochemistry International, vol. 52, no. 7, pp. 1332-1342, 2008.
10. M. L.Weiss, S.Medicetty,A. R. Bledsoe et al., "Humanumbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease," Stem Cells, vol. 24, no. 3, pp. 781-792, 2006.
11. D. Offen, Y. Barhum, Y.-S. Levy et al., "Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease," Journal of Neural Transmission, Supplementa, no. 72, pp. 133-143, 2007.
12. M. Bahat-Stroomza, Y. Barhum, Y. S. Levy et al., "Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in parkinson's disease," Journal ofMolecular Neuroscience, vol. 39, no. 1-2, pp. 199-210, 2009.
13. P. Shetty, G. Ravindran, S. Sarang, A. M. Thakur, H. S. Rao, and C. Viswanathan, "Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease," Cell Biology International, vol. 33, no. 8, pp. 830-838, 2009.
14. M. Hayase,M. Kitada, S.Wakao et al., "Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a ratmodel of stroke," Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 8, pp. 1409-1420, 2009.
15. M. S. Pedram, M. M. Dehghan, M. Soleimani, D. Sharifi, S. H. Marjanmehr, and Z. Nasiri, "Transplantation of a combination of autologous neural differentiated and undifferentiated mesenchymal stem cells into injured spinal cord of rats," Spinal Cord, vol. 48, no. 6, pp. 457-463, 2010.
16. C. M. Kolf, E. Cho, and R. S. Tuan, "Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation," Arthritis Research and Therapy, vol. 9, no. 1, article 204, 2007.
17. D. J. Maltman, S. A. Hardy, and S. A. Przyborski, "Role of mesenchymal stem cells in neurogenesis and nervous system repair," Neurochemistry International, vol. 59,no. 3, pp. 347-356, 2011.
18. J. Liu, L. Song, C. Jiang et al., "Electrophysiological properties and synaptic function of mesenchymal stem cells during neurogenic differentiation-A mini-review," International Journal of Artificial Organs, vol. 35, no. 5, pp. 323-337, 2012.
19. C. A. Ribeiro, A. J. Salgado, J. S. Fraga,N. A. Silva, R. L. Reis, and N. Sousa, "The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures)," Journal of Tissue Engineering and Regenerative Medicine, vol. 5, no. 8, pp. 668-672, 2011.
20. N. Nakano, Y. Nakai, T.-B. Seo et al., "Characterization of conditioned medium of cultured bone marrow stromal cells," Neuroscience Letters, vol. 483, no. 1, pp. 57-61, 2010.
21. X. Chen, M. Katakowski, Y. Li et al., "Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production," Journal of Neuroscience Research, vol. 69, no. 5, pp. 687-691, 2002.
22. R. Qu, Y. Li, Q. Gao et al., "Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts," Neuropathology, vol. 27,no. 4, pp. 355-363, 2007.
23. Y. Li, J. Chen, X. G. Chen et al., "Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery," Neurology, vol. 59, no. 4, pp. 514-523, 2002.
24. K. B. Mackay, S. A. Loddick, G. S. Naeve, A. M. Vana, G. M. Verge, and A. C. Foster, "Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo," Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 10, pp. 1160-1167, 2003.
25. K. Wakabayashi, A. Nagai, A. M. Sheikh et al., "Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model," Journal of Neuroscience Research, vol. 88, no. 5, pp. 1017-1025, 2010.
26. K. T. Wright, W. El Masri, A. Osman et al., "Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A," Biochemical and Biophysical Research Communications, vol. 354, no. 2, pp. 559-566, 2007.
27. N. Kamei, N. Tanaka, Y. Oishi et al., "Bone marrow stromal cells promoting corticospinal axon growth through the release of humoral factors in organotypic cocultures in neonatal rats," Journal of Neurosurgery: Spine, vol. 6, no. 5, pp. 412-419, 2007.
28. T. Führmann, K. Montzka, L. M. Hillen et al., "Axon growthpromoting properties of human bone marrow mesenchymal stromal cells," Neuroscience Letters, vol. 474, no. 1, pp. 37-41, 2010.
29. Y. Gu, J. Wang, F. Ding, N. Hu, Y. Wang, and X. Gu, "Neurotrophic actions of bone marrow stromal cells on primary culture of dorsal root ganglion tissues and neurons," Journal of Molecular Neuroscience, vol. 40, no. 3, pp. 332-341, 2010.
30. P. Lu, L. L. Jones, and M. H. Tuszynski, "BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury," Experimental Neurology, vol. 191, no. 2, pp. 344-360, 2005.
31. B. Neuhuber, B. Timothy Himes, J. S. Shumsky, G. Gallo, and I. Fischer, "Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations," Brain Research, vol. 1035,no. 1, pp. 73-85, 2005.
32. B. T. Himes, B. Neuhuber, C. Coleman et al., "Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord," Neurorehabilitation and Neural Repair, vol. 20, no. 2, pp. 278-296, 2006.
33. A. Shintani, N. Nakao, K. Kakishita, and T. Itakura, "Protection of dopamine neurons by bone marrow stromal cells," Brain Research, vol. 1186, no. 1, pp. 48-55, 2007.
34. F. Wang, T. Yasuhara, T. Shingo et al., "Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1," BMC Neuroscience, vol. 11, article 52, 2010.
35. L. Cova, M.-T. Armentero, E. Zennaro et al., "Multiple neurogenic and neurorescue effects of humanmesenchymal stem cell after transplantation in an experimental model of Parkinson's disease," Brain Research, vol. 1311, pp. 12-27, 2010.
36. C. A. Ribeiro, J. S. Fraga, M.Grãos et al., "Thesecretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations," Stem Cell Research andTherapy, vol. 3, no. 3, article 18, 2012.
37. J. S. Fraga, N. A. Silva, A. S. Lourenço et al., "Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations," Biochimie, vol. 95, pp. 2297-2303, 2013.
38. D.-C. Ding, W.-C. Shyu, M.-F. Chiang et al., "Enhancement of neuroplasticity through upregulation of 1-integrin in human umbilical cord-derived stromal cell implanted stroke model," Neurobiology of Disease, vol. 27, no. 3, pp. 339-353, 2007.
39. S.-H. Koh, K. S. Kim, M. R. Choi et al., "Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats," Brain Research, vol. 1229, pp. 233-248, 2008.
40. Y.-C. Lin, T.-L. Ko, Y.-H. Shih et al., "Human umbilical mesenchymal stem cells promote recovery after ischemic stroke," Stroke, vol. 42, no. 7, pp. 2045-2053, 2011.
41. C.-C. Yang, Y.-H. Shih, M.-H. Ko, S.-Y. Hsu, H. Cheng, and Y.-S. Fu, "Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord," PLoS ONE, vol. 3, no. 10, Article IDe3336, 2008.
42. S.-L. Hu, H.-S. Luo, J.-T. Li et al., "Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cordmesenchymal stem cells," Critical CareMedicine, vol. 38, no. 11, pp. 2181-2189, 2010.
43. R. Blomhoff and H. K. Blomhoff, "Overview of retinoid metabolism and function," Journal of Neurobiology, vol. 66, no. 7, pp. 606-630, 2006.
44. N.A. Silva, J.M.Gimble, N. Sousa, R. L. Reis, and A. J. Salgado, "Combining adult stem cells and olfactory ensheathing cells: the secretome effect," Stem Cells and Development, vol. 22, no. 8, pp. 1232-1240, 2013.
45. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, "Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors," Stem Cells, vol. 23, no. 2, pp. 220-229, 2005.
46. F. M. Lopes, R. Schröder, M. L. Da Frota Jr. et al., "Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies," Brain Research, vol. 1337, pp. 85-94, 2010.
47. M. Encinas, M. Iglesias, Y. Liu et al., "Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells," Journal of Neurochemistry, vol. 75, no. 3, pp. 991-1003, 2000.
48. S. D. Wenker, M. E. Chamorro, D. M. Vota, M. A. Callero, D. C. Vittori, and A. B. Nesse, "Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic aciddifferentiated SH-SY5Y cells," Journal of Cellular Biochemistry, vol. 110, no. 1, pp. 151-161, 2010.
49. M. Pool, J. Thiemann, A. Bar-Or, and A. E. Fournier, "Neurite-Tracer: a novel ImageJ plugin for automated quantification of neurite outgrowth," Journal of Neuroscience Methods, vol. 168, no. 1, pp. 134-139, 2008.
50. R. Constantinescu, A. T. Constantinescu, H. Reichmann, and B. Janetzky, "Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y," Journal of Neural Transmission, Supplementa, no. 72, pp. 17-28, 2007.
51. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method," Methods, vol. 25, no. 4, pp. 402-408, 2001.
52. H.-R. Xie, L.-S. Hu, and G.-Y. Li, "SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease," ChineseMedical Journal, vol. 123, no. 8, pp. 1086-1092, 2010.
53. A. Storch, Y.-I. Hwang, D. A. Gearhart et al., "Dopamine transporter-mediated cytotoxicity of -carbolinium derivatives related to Parkinson's disease: relationship to transporterdependent uptake," Journal of Neurochemistry, vol. 89, no. 3, pp. 685-694, 2004.